Pfizer has recently issued a global recall of Oxbryta, a medication to treat the symptoms of sickle cell disease. Recent studies have shown that Oxbryta — rather than helping those with sickle cell disease—may actually significantly increase the risk of dangerous complications, including vaso-occlusive crises (VOCs) and even death. We are representing clients in actions against Pfizer for these harms with a team of attorneys, case managers and health care experts who have successfully litigated against large and powerful corporate defendents.
If you or a loved one were prescribed Oxbryta for sickle cell disease and experienced worsening symptoms or complications, or death you may be entitled to compensation. Our attorneys are dedicated to holding Pfizer accountable, and we are here to fight for the recovery you deserve.
Understanding Oxbryta
Oxbryta (voxelotor) was marketed as a groundbreaking treatment for sickle cell disease (SCD), designed to increase hemoglobin’s affinity for oxygen and reduce the sickling of red blood cells. Approved by the FDA in 2019, Oxbryta was hailed as a major advancement for people living with SCD. Studies have since revealed that the risks of taking Oxbryta outweigh its benefits. Patients who used the drug faced a higher likelihood of developing severe complications such as VOCs, which can lead to life-threatening outcomes.
Sickle cell disease is an extremely difficult condition to live with, and many patients trusted Oxbryta to manage their condition. Pfizer’s failure to disclose the full scope of the drug’s risks has led to preventable suffering for countless individuals. We are is committed to helping these patients seek justice and compensation.
Serious Health Risks Linked to Oxbryta
Vaso-Occlusive Crises (VOCs): Oxbryta has been linked to an increased risk of VOCs, a painful and dangerous complication of sickle cell disease. VOCs occur when sickled red blood cells block blood flow to tissues, causing severe pain and leading to potential organ damage. Patients who took Oxbryta experienced more frequent VOCs compared to those who did not use the drug, putting them at greater risk of long-term health issues, including kidney failure and stroke.
Fatal Complications: Tragically, some patients who took Oxbryta suffered fatal complications. Studies revealed a higher rate of deaths among those on Oxbryta compared to a placebo, raising serious questions about Pfizer’s safety protocols and commitment to patient welfare.
Law Office of Floyd Chapman, PLLC, is at the forefront of litigation as co-counsel with leading law firms representing individuals and families against Pfizer who have suffered from the severe side effects of Oxbryta. We believe that Pfizer failed to adequately test the drug and disclose the serious risks it posed to sickle cell patients. Our attorneys are working to hold Pfizer accountable for the harm caused by Oxbryta and secure the compensation our clients deserve.
Please fill out the form below and let us review your case.
Victims of Oxbryta may be entitled to compensation for:
Medical Expenses: Covering the costs of hospital visits, treatments, and ongoing care related to VOCs or other complications caused by Oxbryta.
Lost Wages: Compensation for time missed from work due to your illness or treatment.
Pain and Suffering: Damages for the physical and emotional toll of living with the complications caused by Oxbryta.
Punitive Damages: In some cases, courts may award punitive damages to penalize Pfizer for its action.